Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Bernard J. Zovighian

At a glance: Bernard J. Zovighian is CEO at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Nov 9, 2026, reported a sale of $949K. On file: 0 purchase lines ($0) and 10 sale lines ($9.4M).

Disclosed holdings: about $11.2M of EW stock: 107,761 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 9, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO at Edwards Lifesciences Corp (EW)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.4M

Bernard J. Zovighian's InsiderPrint

11 trades from SEC Form 4 filings, 2024 to 2026, drawn as one fingerprint.

InsiderPrint of Bernard J. Zovighian: 11 trades, 2024 to 20262024: 1 buy, 0 sales2025: 0 buys, 2 sales2026: 0 buys, 8 sales

Reading this print: Almost only sells, trading about 4 times a year, typically $322K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (1)
  • Dent inward: a sale (10)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Lazarus KrikorianSvp & Chief Accounting Officer · COR · 100% match
  2. Sharon BrianskySvp, Gc And Secretary · ALGM · 99% match
  3. Heather L. HassonChair · FIGS · 99% match
  4. Ingrid A. EstradaSvp · KEYS · 99% match
  5. Alexandria ForbesCEO, President · MGTX · 98% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 9SEC EWEdwards Lifesciences Corp Sell Plan 9,184112,761 held (−8%) $103.39 $949K +0.3%
Nov 9SEC EWEdwards Lifesciences Corp Sell Plan 13,91698,845 held (−12%) $102.78 $1.4M +0.9%
Jul 27SEC EWEdwards Lifesciences Corp Sell 2,9218,916 held (−25%) $83.93 $245K +23.6%
Jun 17SEC EWEdwards Lifesciences Corp Sell Plan 52311,517 held (−4%) $87.92 $46K +18.0%
May 12SEC EWEdwards Lifesciences Corp Sell Plan 84547,546 held (−2%) $78.40 $66K +32.3%
May 12SEC EWEdwards Lifesciences Corp Sell Plan 35,50612,040 held (−75%) $77.92 $2.8M +33.1%
Feb 13SEC EWEdwards Lifesciences Corp Sell 2,532103,794 held (−2%) $77.13 $195K +34.5%
Feb 13SEC EWEdwards Lifesciences Corp Sell 19,89883,896 held (−19%) $76.61 $1.5M +35.4%
Dec 10SEC EWEdwards Lifesciences Corp Sell Plan 21,48784,839 held (−20%) $85.21 $1.8M +21.7%
Dec 10SEC EWEdwards Lifesciences Corp Sell Plan 3,8638,597 held (−31%) $83.45 $322K +24.3%
  • Sell

    CEO Bernard J Zovighian sold $949K of EW at $103.39 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Bernard J Zovighian sold $1.4M of EW at $102.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Bernard J Zovighian sold $46K of EW at $87.92 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Bernard J Zovighian sold $66K of EW at $78.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Bernard J Zovighian sold $2.8M of EW at $77.92 — cuts the stake by 75%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Bernard J Zovighian sold $1.8M of EW at $85.21 — pre-scheduled 10b5-1 plan sale.

Follow Bernard J. Zovighian

Get one email when Bernard J. Zovighian files a new purchase or sale. Free.

At most one email a day about Bernard J. Zovighian, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.